Treatment of paramyotonia congenita with acetazolamide
- PMID: 3607618
- DOI: 10.1017/s0317167100026305
Treatment of paramyotonia congenita with acetazolamide
Abstract
Treatment of paramyotonia congenita with acetazolamide has been shown to reduce myotonic symptoms but severe weakness has developed in some patients leading to a recommendation not to use the drug in this disorder. We studied a patient with the characteristic clinical and electrophysiological profile of paramyotonia congenita. Myotonia was effectively treated with a very low dose of acetazolamide and no weakness developed. We conclude that acetazolamide can be a safe and effective medication in paramyotonia congenita.